A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2004
12/15/2004	EP1485403A2 Compositions and methods to initiate or enhance antibody and major-histocompatibility class i or class ii-restricted t cell responses by using immunomodulatory, non-coding rna motifs
12/15/2004	EP1485401A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(-2-methoxyl)ethyl modifications
12/15/2004	EP1485346A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
12/15/2004	EP1485124A2 Method of inducing an enhanced immune response against hiv
12/15/2004	EP1485122A2 Novel application of vaccination against tnf-alpha
12/15/2004	EP1485109A1 Vascular therapeutics
12/15/2004	EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
12/15/2004	EP1485067A2 Materials containing multiple layers of vesicles
12/15/2004	EP1453954A4 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
12/15/2004	EP1404845B1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
12/15/2004	EP1212358B1 Synthetic papillomavirus genes optimized for expression in human cells
12/15/2004	EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II
12/15/2004	EP1017283B1 Polynucleotide vaccine formulations
12/15/2004	EP0988391B1 Recombinant adenoviral vectors comprising a splicing sequence
12/15/2004	EP0850310B1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy
12/15/2004	EP0773996B1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF
12/15/2004	CN1555488A Lymphatic endothelial cells materials and methods
12/15/2004	CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system
12/15/2004	CN1555415A Synthetic HCV envelope proteins and their use for vaccination
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1554774A Use of Ard1 gene in mammary cancer diagnosis and treatment
12/15/2004	CN1554766A Pig breeding and respiratory syndrome recombined adenovirus and vaccine
12/15/2004	CN1554764A Recombinant mva virus, and the use thereof
12/14/2004	US6831166 Derivatized oligonucleotides having improved uptake and other properties
12/14/2004	US6831153 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
12/14/2004	US6831070 Delivery of therapeutic gene products by intestinal cell expression
12/14/2004	US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders
12/14/2004	US6830929 In vitro construction of SV40 viruses and pseudoviruses
12/14/2004	US6830902 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
12/14/2004	US6830892 Detecting preferential viral particles in sample; obtain cell, incubate with viral nuclotide sequences, detect transduced cells, monitor cells for preferential phenotypes, detect target particles in preferential cells
12/14/2004	US6830749 Antitumor agents; gene therapy
12/14/2004	CA2296535C Antisense oligonucleotide inhibition of ras
12/14/2004	CA2146320C Antisense oligonucleotide inhibition of the ras gene
12/14/2004	CA2104957C Redirection of cellular immunity by receptor chimeras
12/09/2004	WO2004106523A1 Compositions and methods for preventing and treating liver cirrhosis
12/09/2004	WO2004106517A1 Double-stranded nucleic acid
12/09/2004	WO2004106511A1 OLIGO DOUBLE-STRANDED RNA INHIBITING THE EXPRESSION OF Bcl-2 AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/09/2004	WO2004106505A1 A gutless adenovirus vector and the construction method thereof
12/09/2004	WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004	WO2004106360A2 Viral vectors with improved properties
12/09/2004	WO2004105836A2 Intravenous delivery of polynucleotides to cells in mammalian limb
12/09/2004	WO2004105791A2 Recombinant anti-lhrh vaccines
12/09/2004	WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof
12/09/2004	WO2004069194A9 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
12/09/2004	WO2004062618A3 Method for in vivo regulation of cardiac muscle contractility
12/09/2004	WO2004047736A3 Modulation of bcl2-associated athanogene expression
12/09/2004	WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004	WO2004011624A3 Double stranded rna structures and constructs, and methods for generating and using the same
12/09/2004	WO2004006866A3 Antifungal therapeutic targets
12/09/2004	WO2003100070A3 The frog prince, a transposon vector for gene transfer in vertebrates
12/09/2004	WO2003093478A9 Immunoconjugates for the treatment of tumours
12/09/2004	WO2003087311A3 PrLZ REGULATORY ELEMENTS IN THE TREATMENT OF DISEASE AND THE DISCOVERY OF THERAPEUTICS
12/09/2004	WO2003072114A9 Vascular therapeutics
12/09/2004	WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	WO2002044381A8 Human vno receptor (r1)
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248842 Complexes for transporting nucleic acid into eukaryotic higher-cells
12/09/2004	US20040248841 Genetic engineered Dna; stability, efficiency; Rna interference
12/09/2004	US20040248840 Oligomeric compounds for the modulation of ras expression
12/09/2004	US20040248839 RNAi targeting of viruses
12/09/2004	US20040248838 Human and mouse choline transporter cDNA
12/09/2004	US20040248837 Methods of treating pulmonary fibrotic disorders
12/09/2004	US20040248836 Administering activator of formin homologue overexpression in spleen; adjusting gene expression
12/09/2004	US20040248833 Therapeutic delivery compositions and methods of use thereof
12/09/2004	US20040248832 Enhancement of transfection of dna into the liver
12/09/2004	US20040248831 Oligodeoxynucleic acid modified with (thio)phosphate
12/09/2004	US20040248830 Agents that regulate apoptosis
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248828 Antisense modulation of interleukin 12 p35 subunit expression
12/09/2004	US20040248827 Replicative defective
12/09/2004	US20040248826 Treatment of cancer by in vivo gene-transfer induced TIMP-3 expression
12/09/2004	US20040248798 Contraceptive methods and compositions related to proteasomal interference
12/09/2004	US20040248796 VEGF-B and PDGF modulation of stem cells
12/09/2004	US20040248794 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
12/09/2004	US20040248785 mutant factor VIII has procoagulant activity; increased half-life; substituted amino acid(s) in the A2 domain
12/09/2004	US20040248766 Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248301 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
12/09/2004	US20040248300 Plasmid construct for use in transfer and expression of heterologous gene sequences for use in treatment of nervous system disorders in mammals
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248288 Compositions and methods for efficient aav vector production
12/09/2004	US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders
12/09/2004	US20040248261 Feline IL-12 single chain proteins and nucleic acid molecules
12/09/2004	US20040248256 Secreted proteins and polynucleotides encoding them
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248246 Compositions and methods for enhancing differential expression
12/09/2004	US20040248245 Zinc activated ion channel
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248184 Regeneration protein for use in diagnosis, prevention and treatment of diabetes and cardiovascular disorders; antidiabetic agents
12/09/2004	US20040248175 Embryogenic regulatory protein for use in diagnosis, prevention and treatment of cell proliferative and reproductive disorders
12/09/2004	US20040248174 Small interfering RNA sequences for use in prevention and treatment of vision defects, inflammation, cardiovascular and cell proliferative disorders; RNA interference; gene expression inhibition
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248160 Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof

1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 870